Alimera Sciences, Inc.
ALIM · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $110,428 | $18,962 | $33,832 | $21,598 |
| - Cash | $12,090 | $5,274 | $16,510 | $11,208 |
| + Debt | $67,399 | $44,329 | $43,569 | $44,612 |
| Enterprise Value | $165,737 | $58,017 | $60,891 | $55,002 |
| Revenue | $80,754 | $54,129 | $59,029 | $50,820 |
| % Growth | 49.2% | -8.3% | 16.2% | – |
| Gross Profit | $61,170 | $46,152 | $51,999 | $43,879 |
| % Margin | 75.7% | 85.3% | 88.1% | 86.3% |
| EBITDA | -$1,115 | -$9,492 | $4,058 | $2,649 |
| % Margin | -1.4% | -17.5% | 6.9% | 5.2% |
| Net Income | -$20,132 | -$18,107 | -$4,372 | -$5,339 |
| % Margin | -24.9% | -33.5% | -7.4% | -10.5% |
| EPS Diluted | -0.79 | -2.59 | -0.66 | -1.04 |
| % Growth | 69.5% | -292.4% | 36.5% | – |
| Operating Cash Flow | -$14,261 | -$9,975 | -$3,224 | -$2,193 |
| Capital Expenditures | -$75,532 | -$255 | -$621 | -$620 |
| Free Cash Flow | -$89,793 | -$10,230 | -$3,845 | -$2,813 |